Mark C. McKenna, Director: Apogee Therapeutics APGE Buy · Filed 24/12/16

Trade details

Type: Insider buy
Amount: $623,125
Shares · price: 12,500 sh · $49.85 a share
Held after: 20,000 sh
Stock: Apogee Therapeutics APGE
Person: Mark C. McKennaDirector
Trade date: 24/12/12
Filed: 24/12/16
Days to filing: 4 days

First buy since 2023

Insiders buying this week: 1 insiders
Holding change: +166.7%

Apogee Therapeutics trades, last 26 weeks

What else happened in Apogee Therapeutics around then

Filed or reported within 30 days of the trade day · 24/11/12~25/01/11

Mark C. McKenna's recent trades

Mark C. McKennaDirector
BuyApogee Therapeutics
Buy
Apogee Therapeutics
APGE
$367.7K
7,500 sh
$367.7K
Filed 24/12/16
Traded 24/12/12
Mark C. McKennaChairman, President & CEO
SellPrometheus Biosciences
Sell
Prometheus Biosciences
RXDX
$2.9M
25,000 sh
$2.9M
Filed 23/03/17
Traded 23/03/15
Mark C. McKennaChairman, President & CEO
SellPrometheus Biosciences
Sell
Prometheus Biosciences
RXDX
$1.3M
10,620 sh
$1.3M
Filed 23/03/03
Traded 23/03/03
Mark C. McKennaChairman, President & CEO
SellPrometheus Biosciences
Sell
Prometheus Biosciences
RXDX
$87.7K
700 sh
$87.7K
Filed 23/03/03
Traded 23/03/01
Mark C. McKennaChairman, President & CEO
SellPrometheus Biosciences
Sell
Prometheus Biosciences
RXDX
$3M
25,000 sh
$3M
Filed 23/02/17
Traded 23/02/16

Mark C. McKenna, Director — bought $623.1K of Apogee Therapeutics APGE · 12,500 sh @ $49.85 | Whalegun